A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma.
Garcia G, Magnan A, Chiron R, Contin-Bordes C, Berger P, Taillé C, Devouassoux G, de Blay F, Couderc LJ, Didier A, O'Callaghan DS, Girodet PO, Bourdeix I, Le Gros V, Humbert M.
Garcia G, et al. Among authors: bourdeix i.
Chest. 2013 Aug;144(2):411-419. doi: 10.1378/chest.12-1961.
Chest. 2013.
PMID: 23579324
Clinical Trial.